Title:
FUSED RING DERIVATIVE AS A2A RECEPTOR INHIBITOR
Document Type and Number:
WIPO Patent Application WO/2019/062803
Kind Code:
A1
Abstract:
Disclosed are a compound represented by formula (I) or a pharmaceutically-acceptable salt thereof, and an application of the compound or salt in preparation of drugs for treating diseases related to an A2A receptor.
Inventors:
CHEN KEVIN X (CN)
ZHOU KAI (CN)
HU BOYU (CN)
XIAO MINLIANG (CN)
CHEN SHUHUI (CN)
ZHOU KAI (CN)
HU BOYU (CN)
XIAO MINLIANG (CN)
CHEN SHUHUI (CN)
Application Number:
PCT/CN2018/107899
Publication Date:
April 04, 2019
Filing Date:
September 27, 2018
Export Citation:
Assignee:
CSTONE PHARMACEUTICALS (GB)
CSTONE PHARMACEUTICAL SUZHOU CO LTD (CN)
CSTONE PHARMACEUTICALS SHANGHAI CO LTD (CN)
MEDSHINE DISCOVERY INC (CN)
CSTONE PHARMACEUTICAL SUZHOU CO LTD (CN)
CSTONE PHARMACEUTICALS SHANGHAI CO LTD (CN)
MEDSHINE DISCOVERY INC (CN)
International Classes:
C07D417/02; A61K31/00; A61K31/41; A61P25/00; C07D417/10
Domestic Patent References:
| WO2015020565A1 | 2015-02-12 |
Foreign References:
| CN105025899A | 2015-11-04 | |||
| CN1437471A | 2003-08-20 | |||
| CN201710900542A | 2017-09-28 | |||
| CN201810239824A | 2018-03-21 |
Other References:
See also references of EP 3686199A4
Attorney, Agent or Firm:
SHANGHAI BESHINING LAW OFFICE (CN)
Download PDF: